Franceschi William, Bliggenstorfer Jonathan, Sarode Anuja L, Ginesi Meridith, Steinhagen Emily, Stein Sharon L
Department of General Surgery, Case Western Reserve University School of Medicine, Cleveland, USA.
Department of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.
Cureus. 2023 May 30;15(5):e39735. doi: 10.7759/cureus.39735. eCollection 2023 May.
Introduction Although rectal cancer is thought to have a higher rate of metastasis to the brain compared with colon cancer, there is limited and contradictory data on the subject. This study aims to determine the prevalence of brain metastasis for colon and rectal cancers (CRC), and to explore associations and predictors of brain metastasis (BM). Methods The 2010-2016 National Cancer Database (NCDB) was queried for patients with stage IV CRC. Patients with missing data on site of metastasis and primary tumor location were excluded. Chi-square test was used for categorical data and multivariate logistic regression analysis was performed to evaluate the predictors of BM. Results Of 108,540 stage IV CRC patients, the prevalence of BM was 1.21% from the right colon, 1.29% from the left colon, and 1.59% from the rectal adenocarcinoma (p<0.001). The presence of lung, bone, and liver metastases were the strongest predictors for BM. Bone and lung metastases increased the odds for BM by 3.87 (95% CI: 3.36-4.46) and 3.38 (95% CI: 3.01-3.80), respectively while the presence of liver metastasis decreased odds for BM by 55% (OR: 0.45; 95% CI: 0.40-0.50). On multivariate analysis, primary tumor location was not predictive of BM. Discussion This study helps to characterize the prevalence and associations of BM from CRC using the NCDB. The correlation between BM and bone and lung metastases, along with negative association of liver metastasis further supports the hypothesis of systemic transmission of tumor cells. Further identification of predictors and correlations with BM may help guide surveillance among patients with advanced CRC.
虽然一般认为直肠癌相较于结肠癌有更高的脑转移率,但关于这一主题的数据有限且相互矛盾。本研究旨在确定结肠癌和直肠癌(CRC)脑转移的发生率,并探讨脑转移(BM)的相关因素及预测指标。方法:查询2010 - 2016年国家癌症数据库(NCDB)中IV期CRC患者。排除转移部位和原发肿瘤位置数据缺失的患者。分类数据采用卡方检验,并进行多因素逻辑回归分析以评估BM的预测指标。结果:在108,540例IV期CRC患者中,右半结肠癌脑转移发生率为1.21%,左半结肠癌为1.29%,直肠腺癌为1.59%(p<0.001)。肺、骨和肝转移的存在是BM最强的预测指标。骨转移和肺转移使BM的发生几率分别增加3.87(95%CI:3.36 - 4.46)和3.38(95%CI:3.01 - 3.80),而肝转移的存在使BM的发生几率降低55%(OR:0.45;95%CI:0.40 - 0.50)。多因素分析显示,原发肿瘤位置不能预测BM。讨论:本研究有助于利用NCDB描述CRC脑转移的发生率及相关因素。BM与骨和肺转移之间的相关性,以及与肝转移的负相关性进一步支持了肿瘤细胞全身播散的假说。进一步确定BM的预测指标及其相关性可能有助于指导晚期CRC患者的监测。